Target intelligence / Profile preview

Poliovirus immunity

01

Overview

"Poliovirus immunity" refers to the body's adaptive immune response following infection or vaccination against poliovirus. Immunity is primarily mediated by the production of neutralizing antibodies: *IgA* antibodies in the gastrointestinal mucosa prevent virus replication and shedding, while *IgG* and *IgM* antibodies in the blood prevent systemic spread and invasion of the central nervous system. Vaccines (OPV and IPV) are designed to elicit these protective immune responses, and robust mucosal immunity is particularly important in halting poliovirus transmission. Immunity to one serotype of poliovirus does not confer protection against the others, so broad protection requires exposure or vaccination against all three serotypes[3][4][7][8].

02

Mechanism of action

Induction of neutralizing antibodies (mainly IgA in the gut, IgG and IgM in serum) that block virus replication and prevent spread to the CNS

03

Biological functions

Immune response
04

Disease associations

Infection
05

Safety considerations

Oral vaccine may rarely cause vaccine-derived poliovirus or vaccine-associated paralytic poliomyelitis (very rare adverse event)Immunodeficient individuals may fail to develop immunity or suffer complications
06

Interacting drugs

Oral poliovirus vaccine (OPV)

2 more in the full profile.

07

Biomarkers

Poliovirus-specific neutralizing antibody titers (serum IgA, IgG, IgM, and mucosal IgA)

Beyond the preview

Go deeper on Poliovirus immunity.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Poliovirus immunity.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call